Orchard Therapeutics said Thursday it has laid off about a quarter of its staff, given up on a new manufacturing facility in California and shifted its clinical focus, as the gene therapy company looks to preserve cash and focus on higher value products.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,